Not sure if this is an earnest defense of the state of healthcare costs in the US but you'd have to be deluded if you think that the rampant profit-seeking in the US for healthcare is merely the cost of doing business.
It's brand name drugs that are cheaper in other countries.
[1]https://www.who.int/intellectualproperty/events/en/R&Dpaper2...
That's orthogonal to universal healthcare or even a single payer system. There's nothing preventing you from having the whole country be represented collectively, but still have private insurers, like in germany. https://www.commonwealthfund.org/blog/2019/how-drug-prices-a...
It's important, because using the wrong/imprecise terminology muddles the conversation, and allowing it to go uncorrected normalizes it. When it comes to something like politics, all this will lead to is more polarization.